[Federal Register Volume 73, Number 48 (Tuesday, March 11, 2008)]
[Notices]
[Page 13006]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-4849]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Office of
Biotechnology Activity; Recombinant DNA Research; Notice of a Meeting
of an NIH Blue Ribbon Panel
There will be a meeting of the NIH Blue Ribbon Panel to advise on
the Risk Assessment of the National Emerging Infectious Disease
Laboratory at Boston University Medical Center. The meeting will be
held on Thursday, March 13, 2008, at the National Institutes of Health,
Building 1, Wilson Hall, 1 Center Drive, Bethesda, Maryland 20892, from
8:30 a.m. to approximately 2 p.m.
Discussion will include the charge to the Panel, an overview of the
principles of environmental protection laws, and risk assessment
studies.
For further information concerning this meeting contact Ms. Laurie
Lewallen, Advisory Committee Coordinator, Office of Biotechnology
Activities, Office of the Director, National Institutes of Health, 6705
Rockledge Drive, Room 750, Bethesda, MD 20892-7985, 301-496-9838,
[email protected].
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed above in
advance of the meeting. Any interested person may file written comments
with the panel by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one form
of identification (for example, a government-issued photo ID, driver's
license, or passport) and to state the purpose of their visit.
An agenda and any additional information for the meeting will be
posted on the agency's Web site: http://www.nih.gov/about/director/acd/index.htm.
Background information may be obtained by contacting NIH OBA by e-
mail [email protected].
Dated: March 4, 2008.
Amy P. Patterson,
Director, Office of Biotechnology Activities.
[FR Doc. E8-4849 Filed 3-10-08; 8:45 am]
BILLING CODE 4140-01-P